Status:
COMPLETED
Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Non-small Cell Lung Cancer
Small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to compare two types of care - standard oncology care and standard oncology care with early palliative care (started soon after diagnosis) to see which is better for impro...
Detailed Description
Subjects and their caregiver will complete a baseline questionnaire and then be randomized to a study group. Subjects who are randomized to Standard Oncology Care will follow up with their treating o...
Eligibility Criteria
Inclusion
- Confirmed metastatic lung cancer (NSCLC, small cell lung cancer, and mesothelioma)or non-colorectal GI cancer (esophageal, gastric and hepatobiliary) not being treated with curative intent
- Informed of metastatic disease within the previous 8 weeks
- No prior therapy for metastatic disease
- Able to read questions in English or willing to complete questionnaires with the assistance of an interpreter
- Relative or friend of patient who will likely accompany the patient to clinic visits
Exclusion
- Significant psychiatric or other co-morbid disease
Key Trial Info
Start Date :
May 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2019
Estimated Enrollment :
351 Patients enrolled
Trial Details
Trial ID
NCT01401907
Start Date
May 1 2011
End Date
December 1 2019
Last Update
October 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114